Replies to post #213930 on Biotech Values

[bladerunner1717]

re: ADVM

ghmm,

With nothing yet in the clinic, where do you see the value-drivers in the company pipeline?


Bladerunner

[DewDiligence]

ADVM sells 10.22M* shares @$6.75—a 5% discount to yesterday’s close:

https://finance.yahoo.com/news/adverum-biotechnologies-announces-pricing-60-130000422.html

*Assuming exercise of underwriter’s option.